MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 246 filers reported holding MIRATI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,917,000 | -24.7% | 27,445 | -27.7% | 0.29% | +28.9% |
| Q2 2022 | $2,547,000 | +444.2% | 37,944 | +1682.2% | 0.22% | +603.1% |
| Q4 2020 | $468,000 | -36.5% | 2,129 | -91.1% | 0.03% | +28.0% |
| Q1 2018 | $737,000 | +60.2% | 24,015 | -4.8% | 0.02% | +92.3% |
| Q4 2017 | $460,000 | -42.4% | 25,224 | -63.0% | 0.01% | -50.0% |
| Q3 2017 | $798,000 | +299.0% | 68,200 | +24.7% | 0.03% | +225.0% |
| Q2 2017 | $200,000 | -66.0% | 54,700 | +194.1% | 0.01% | -90.1% |
| Q4 2015 | $588,000 | -8.1% | 18,600 | 0.0% | 0.08% | +478.6% |
| Q3 2015 | $640,000 | +127.0% | 18,600 | +107.8% | 0.01% | +100.0% |
| Q2 2015 | $282,000 | – | 8,952 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |